Time Warner Inc. (NYSE: TWX) and Time Warner Cable (NYSE:TWC) shares have been a bit stalled because investors are wondering what is coming. The company has been in a strategic review period since last earnings, but no one knows if the parent is going to unload more cable stock. A Reuters article last week pointed to the issue of whether shares would be coming, but the answer is still unknown. The speculation is roughly equal on both sides, but the ultimate answer is probably somewhere in the middle and the company did say this was an option.
But there is another issue to consider, mostly because Time Warner itself doesn't want to lose control of the cable unit any time soon. If it sells shares on its own behalf then it can unlock more value. But if it sells too much then the actual cable unit itself would have to use cash to make acquisition deals when it can.
This is a conundrum for shareholders in both stocks. The parent could probably raise another $3.7 billion in cash if it sold another 10% of the cable subsidiary unit, but then it has another 20% to use for acquisitions or distribution before its gets under the 50% majority stake. The company already bought back more than enough stock, and Carl Icahn is still present, but mostly out of the stock and is not making any more waves. If it does sell cable shares from here, then the parent needs to use the cash for bolstering business rather than continuing more and more buybacks.
Jon Ogg can be reached at jonogg@247wallst.com; he does not own securities in the companies he covers.
Last updated: February 10, 2012: 02:26 PM
Hot Stocks
DailyFinance Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
Benzinga Headlines
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
- The Pepsi Challenge for 8,700 People is to Find a New Job
TheFlyOnTheWall.com Headlines
- Market lower, moving in narrow range
- MSCI Italy Index volatility increases on S&P downgrade of Italy-based banks
- Mattel sees no material impact in 2012 from HiT acquisition
- Apple reverses lower, support is at $488.55
- Mattel targets 2012 year end cash $800M-$1B
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
- Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger
- Why Groupon Will Never Be Great Again
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Savings Experiment: Snow Removal
The Money Man Behind Rick Santorum: Who Is Foster S. Friess?

